Thomas Gayner - Markel Asset Management
Holding/activity history for Regeneron Pharmaceuticals (REGN)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
| 2023 Q1 | 0 | 0 | Sell 100.00% | 0.30 | |
| 2022 Q4 | 30,500 | 0.30 | Reduce 62.02% | 0.49 | $721.48 |
| 2022 Q3 | 80,300 | 0.82 | $688.88 | ||
| 2022 Q2 | 80,300 | 0.68 | $591.12 | ||
| 2022 Q1 | 80,300 | 0.67 | Add 1.26% | 0.01 | $698.42 |
| 2021 Q4 | 79,300 | 0.57 | Add 6.73% | 0.04 | $631.53 |
| 2021 Q3 | 74,300 | 0.57 | Add 11.23% | 0.06 | $605.18 |
| 2021 Q2 | 66,800 | 0.47 | Add 46.81% | 0.15 | $558.53 |
| 2021 Q1 | 45,500 | 0.30 | Buy | 0.30 | $473.14 |